Razelle Kurzrock, MD, FACP
Center Associate Director, Professor
Locations
- Froedtert Hospital
- Clinical Cancer Center - Froedtert Hospital
Specialties
- Medical Oncology
Languages
- English
Clinical Cancer Center - Froedtert Hospital
Education
- MD - Doctor of Medicine
- FACP - Fellow of the American College of Physicians
Leadership Positions
- Associate Director of Clinical Research, Cancer Center
- Associate Director of Clinical Research, GSPMC
Publications
-
(Ahmed J, Nishizaki D, Fujiwara Y, DePietro P, Jensen TJ, McFall T, Kato S, Kurzrock R.) ESMO Open. 2026 Jun;11(6):107768 PMID: 42263481 PMCID: PMC13272506 SCOPUS ID: 2-s2.0-105041408368 06/10/2026
-
(Fujiwara Y, Kato S, Nishizaki D, Miyashita H, Lee S, Jensen TJ, DePietro P, Seager RJ, Ikeda S, Kurzrock R.) NPJ Precis Oncol. 2026 Apr 28;10(1) PMID: 42049950 PMCID: PMC13328500 SCOPUS ID: 2-s2.0-105043594073 04/29/2026
-
(Patel SP, Othus M, Chae YK, Azenkot T, Alviz C, Threlkel S, Haymaker C, Streicher HZ, Magner CM, Chen HX, Sharon E, Ryan CW, Blanke CD, Kurzrock R.) Ann Oncol. 2026 Apr 15 PMID: 41997295 SCOPUS ID: 2-s2.0-105041120991 04/18/2026
-
Winning the war against cancer in the precision era: it's about time.
(Shreenivas A, Wahida A, Kurzrock R.) Signal Transduct Target Ther. 2026 Apr 02;11(1) PMID: 41927529 PMCID: PMC13046751 SCOPUS ID: 2-s2.0-105034871481 04/03/2026
-
(Low SK, Fujiwara Y, Nishizaki D, Kato S, Kurzrock R.) J Immunother Precis Oncol. 2026 Apr;9(2):36-45 PMID: 41994077 PMCID: PMC13078950 SCOPUS ID: 2-s2.0-105043493651 04/17/2026
-
Living Guidelines for Tumor-Agnostic Therapies: A Pathway to Next-Generation Cancer Treatment.
(Subbiah V, Oliver TK, Palma J, Kurzrock R.) JCO Precis Oncol. 2026 Apr;10(4):e2500767 PMID: 41931741 SCOPUS ID: 2-s2.0-105042133213 04/03/2026
-
(Swiecicki PL, Othus M, Patel SP, Kwang-Chae Y, Kurzrock R.) Cancer. 2026 Apr 01;132(7):e70374 PMID: 41892875 PMCID: PMC13025072 SCOPUS ID: 2-s2.0-105034533123 03/27/2026
-
(Chae YK, Othus M, Lyu J, Lee S, Paik S, Dietrich E, Jung CM, Chung LI, Patel S, Kurzrock R.) J Immunother Cancer. 2026 Mar 11;14(3) PMID: 41819545 PMCID: PMC12983688 SCOPUS ID: 2-s2.0-105033433568 03/13/2026
-
(Dişel U, Kato S, Shreenivas A, Danyeli AE, Ahluwalia MS, Kurzrock R.) J Immunother Precis Oncol. 2026 Feb;9(1):25-31 PMID: 41868199 PMCID: PMC13004655 SCOPUS ID: 2-s2.0-105043508430 03/23/2026
-
OX40 transcriptomic expression and its association with immune checkpoints and clinical outcomes.
(Thapa B, Nishizaki D, Miyashita H, Lee S, Nesline MK, Previs RA, Conroy JM, Jensen TJ, DePietro P, Pabla S, Kato S, Kurzrock R.) Ther Adv Med Oncol. 2026;18:17588359261456325 PMID: 42453651 PMCID: PMC13365659 SCOPUS ID: 2-s2.0-105044508814 07/15/2026
-
ERBB2/HER2 landscape and prognostic impact: large-scale, real-world analysis across solid cancers
(Shreenivas A, Elliott A, Corbiere T, Chen HZ, George B, Kamgar M, Chakrabarti S, Desai A, Bracken-Clarke D, Xue E, Floudas CS, Thomas J, Xiu J, Sledge G, Antonarakis ES, Boumber Y, Kurzrock R.) ESMO Open. July 2026;11(7) SCOPUS ID: 2-s2.0-105041663052 07/01/2026
-
(Narvel H, Nishizaki D, Jensen TJ, Seager RJ, DePietro P, Kato S, Kurzrock R.) Journal of Clinical Oncology. May 2026;44(16):2585-2585 SCOPUS ID: 2-s2.0-105041935312 05/27/2026